pixie this extact from their latest announ. says it all.
based on this statement they must be in advanced negotiations with someone otherwise how would they know that commercialisation costs will be bourne by their partner.what would happen if a partner didnt agree to this. i suspect a development in this area ie. PRRS soon. i suspect merial might be interested.
my opinion only.read disclaimer at the bottom
progress to regulatory trials in the principal target markets of the USA and Europe. These are likely to be conducted with commercial partners in the northern hemisphere. PRRS does not currently occur in Australia. "Negotiations will be advanced more rapidly with large global animal health companies to progress external validation trials prior to licensing arrangements. Costs for the PRRS vaccine product development will be borne by the licensing partner," stated Dr Lamb.
pixiemops chat
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $716.4M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.0¢ | $4.569M | 43.47M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 81 | 11802437 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 1548686 | 12 |
View Market Depth
| Last trade - 16.10pm 01/12/2023 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
-0.010 ( 8.14 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.5¢ | 10.0¢ | 23114205 | ||
| Last updated 16.09pm 01/12/2023 ? | |||||
| IMU (ASX) Chart |